These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5897224)

  • 21. [Experiments with nitrofurantoin: pH dependence of the antibacterial effect].
    Hein H
    Med Welt; 1967 Sep; 36():2115-21. PubMed ID: 5614248
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapeutic strategies involving antimicrobial treatment of the canine urinary tract.
    Ling GV
    J Am Vet Med Assoc; 1984 Nov; 185(10):1162-4. PubMed ID: 6392247
    [No Abstract]   [Full Text] [Related]  

  • 23. [Uncomplicated urinary tract infections, what about fosfomycin and nitrofurantoin in 2006?].
    Honderlick P; Cahen P; Gravisse J; Vignon D
    Pathol Biol (Paris); 2006; 54(8-9):462-6. PubMed ID: 17027182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development of resistance to antibiotics and chemotherapy in the most common causative agents of urinary tract infection during 1956-1965].
    Gayer J; Wundt W; Haug HU
    Med Welt; 1966 Mar; 13():617-23. PubMed ID: 5974255
    [No Abstract]   [Full Text] [Related]  

  • 25. [Profile and sensitivity to antibiotics of 2063 uropathogenic bacteria isolated in the center of Tunisia].
    Boukadida J; Boukadida N; Elraii S
    Bull Soc Pathol Exot; 2002 Mar; 95(1):8-10. PubMed ID: 12012968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An update on the role of nitrofurans in the management of urinary tract infections.
    Guay DR
    Drugs; 2001; 61(3):353-64. PubMed ID: 11293646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli.
    Sandegren L; Lindqvist A; Kahlmeter G; Andersson DI
    J Antimicrob Chemother; 2008 Sep; 62(3):495-503. PubMed ID: 18544599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection.
    Stein GE
    Clin Ther; 1999 Nov; 21(11):1864-72. PubMed ID: 10890258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gram-negative organisms of urinary tract and furadantin: a study in vitro.
    Naidu ML; Rao KS
    Indian J Med Res; 1967 Jul; 55(7):699-705. PubMed ID: 6056280
    [No Abstract]   [Full Text] [Related]  

  • 30. Antimicrobial susceptibility of urinary tract pathogens--community acquired strains.
    Waters MJ; Andrew JH
    Aust N Z J Med; 1986 Feb; 16(1):84-5. PubMed ID: 3458455
    [No Abstract]   [Full Text] [Related]  

  • 31. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
    Karlowsky JA; Thornsberry C; Jones ME; Sahm DF
    Clin Infect Dis; 2003 Jan; 36(2):183-7. PubMed ID: 12522750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical implications. In vitro resistance of E coli to TMP/SMX.
    Postgrad Med; 2001 Aug; 110(2 Suppl):11-5; discussion 26-7. PubMed ID: 19667571
    [No Abstract]   [Full Text] [Related]  

  • 33. Chemotherapeutic drugs and susceptibility testing.
    Cravitz L
    JAMA; 1966 Jul; 197(3):231. PubMed ID: 15214399
    [No Abstract]   [Full Text] [Related]  

  • 34. [Urine culture analysis in children with urinary tract infections treated at Pediatric Clinical Department in Bytom in the years 1998-1999].
    Zmudzińska-Kitczak J; Kniazewska M; Dyla L; Wiczkowski A; Obuchowicz A; Bukowska C; Skałba-Skarbska M
    Pol Merkur Lekarski; 2000 Apr; 8(46):238-9. PubMed ID: 10897628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
    Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
    Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The status of antibiotic sensitivity of Vibrio cholerae 0:1 in Ecuador].
    Aldighieri S; Vela E; Pesantes C
    Med Trop (Mars); 1997; 57(1):98. PubMed ID: 9289622
    [No Abstract]   [Full Text] [Related]  

  • 37. Susceptibility of recent bacterial isolates to cefdinir and selected antibiotics among children with urinary tract infections.
    Bonsu BK; Shuler L; Sawicki L; Dorst P; Cohen DM
    Acad Emerg Med; 2006 Jan; 13(1):76-81. PubMed ID: 16365328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary tract infection and drug-resistant bacteria in different patient populations.
    Nitzan Y; Maayan M; Wajsman C; Drucker M
    Isr J Med Sci; 1983 Dec; 19(12):1039-45. PubMed ID: 6363352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The use of Maxaquin (lomefloxacin hydrochloride) in the treatment of nonspecific inflammatory diseases and in the prevention of surgical interventions in urology].
    Derevianko II; Lopatkin NA; Khodyreva LA; Kondrat'eva EM
    Urol Nefrol (Mosk); 1998; (5):14-8. PubMed ID: 9820038
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).
    Zhanel GG; Hisanaga TL; Laing NM; DeCorby MR; Nichol KA; Palatnik LP; Johnson J; Noreddin A; Harding GK; Nicolle LE; Hoban DJ;
    Int J Antimicrob Agents; 2005 Nov; 26(5):380-8. PubMed ID: 16243229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.